J"I want to go back to my little grass shack".
One of my favs. And where I'm heading in about 30 minutes! (but it's on Kauai and not in Kealakekua!)
J"I want to go back to my little grass shack".
Roscoe nailed it! with the exception of "kakahi'aka" for 'everyone.
We had to evacuate last nite at 1am for the Japan tsunami, which, luckily, only hit a couple spots in the islands with any real damage. Just now getting back home at 1pm. They evacuated all the ground floors of the hotels statewide........
****k you Julie!Since it embarrasses you, I'm not going to say "thank you, Julie".

I was counting the asterisks on that one, Our House.![]()
![]()


You can "welcome" me all you want, Julie, I'm still not going to say "thank you".![]()

Thompson Hine traces its origination back to 1893 when Amos Burt (A.B.) Thompson, an enterprising, self-taught attorney, was admitted to the Ohio Bar and established a commercial law practice in downtown Cleveland. Mr. Thompson went into partnership first with Charles P. Hine and later, in 1911, with Walter L. Flory, whereupon the firm adopted the name it kept for 90 years, Thompson, Hine and Flory.
Top Court Cases of 2010 to be Discussed at Annual Conference, April 5-6
In conjunction with the release of FDLI's publication, Top 20 Food and Drug Cases, 2010 & Cases to Watch, 2011, this panel will present three of the most watched cases from this past year. The session will also include an update on last year's Top 20 Cases and a preview of the cases to watch in 2011. Cases to be discussed include: Matrixx Initiatives, Inc. v. Siracusano (SEC and a drug company's nondisclosure of adverse event reports), Bryant v. Medtronic, Inc. (the first major appellate post-Riegel ruling), and Smoking Everywhere and Sottera Inc. v. FDA (electronic cigarette ruling). Presenters are all leading academics teaching food and drug case law.
John B. Reiss, Partner, Saul Ewing LLP (Moderator)
Lewis A. Grossman, Professor of Law, Associate Dean for Scholarship, American University, and Of Counsel, Covington & Burling LLP
William M. Janssen, Assistant Professor of Law, Charleston School of Law
Margaret Sova McCabe, Professor of Law, University of New Hampshire School of Law
Jordan K. Paradise, Associate Professor of Law, Seton Hall University School of Law
Register for the FDLI Annual conference today.
TUESDAY, APRIL 5, 2011
2:00-3:30 p.m.
Concurrent Breakout Sessions:
E. Tobacco Products
Lawrence R. Deyton, MSPH, MD
Director, Center for Tobacco Products (CTP), FDA
- - -
4:00-5:30 p.m.
Concurrent Breakout Sessions
E. Development and Regulation of Tobacco Products, Nicotine
and Alternative Tobacco Products under the Family
Smoking Prevention and Tobacco Control Act and Beyond
Under the Family Smoking Prevention and Tobacco Control Act ("Tobacco Control Act"), FDA has broad authority to regulate tobacco products, but cannot ban tobacco products or nicotine. Rather than permit FDA to regulate all tobacco, nicotine, and alternative tobacco products in a single center or as its own group of products, the Tobacco Control Act created a regulatory scheme that fragmented these products into different FDA centers of responsibilities-tobacco products, drugs, foods, or combinations of these products. Recently, FDA has faced challenges determining how to classify and regulate e-cigarettes and will undoubtedly face more challenges with definitions created by the Tobacco Control Act such as "cigarette" or "tobacco product", as the tobacco industry creates hybrid products, such as cigarillos, or new products including noncombustible tobacco products, such as dissolvable tobacco. During this thought-provoking session, the panelists will create a dynamic forum for the audience to listen and react to concerns raised by the panelists about the Tobacco Control Act and its effect on the development and regulation of tobacco, nicotine, and alternative tobacco products and proposals for how FDA may address these issues in the coming months and years. In particular, the panel will raise issues about how FDA and Congress can better address the public health concern to develop more reduced risk tobacco, nicotine and alternative tobacco products, as well cope with the requirements set by the Tobacco Control Act to define limits for harmful constituents in tobacco products and ban or reduce the limit of substances used to make tobacco products more addictive or palatable and thereby encourage new or continued use.
Moderator Roseann B. Termini
MEd, Professor, Widener University School of Law
Speaker/Panelists
Scott D. Ballin
Health Policy Consultant
Brian J. Malkin
Partner, Frommer Lawrence & Haug LLP
David T. Sweanor
Adjunct Professor, Faculty of Law, University of Ottawa
Nothing new at the district court level with either NJOY or TW . . . new filing in the NJOY Court of Appeals case . . . the Alphabet Soup Group has substituted counsel. Nothing significant, though . . . looks like the old attorney has switched law firms and has withdrawn as counsel. The Alphabet Soup Group is being represented by a new lawyer with the old law firm.
Attached Files
Alphabet Soup - Substitution of Counsel in Ct.App. SE:NJOY case.pdf (16.2 KB, 5 views)